Cost-effectiveness evidence for introducing and sustaining a vaccine case study: Italy – Hepatitis B

For many years, the Immunization Economics Community of Practice has supported researchers, policymakers, and practitioners around the world to use economic evidence to make better immunization decisions so that limited resources can save more lives.

Our work has been generously supported by the Gates Foundation and Gavi, the Vaccine Alliance, but our current funding ends this year. We are now seeking donations to help us bridge this transition and keep the community alive.